Acute hepatitis C virus infection: Diagnosis, pathogenesis, treatment

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Diagnosing acute hepatitis C (HCV) presents challenges due to asymptomatic presentation and lack of specific tests.
• Current diagnosis relies on antibody seroconversion and RT-PCR for HCV-RNA, with double seroconversion being less common.
• HCV infection progression is linked to immune response intensity, cytokine profiles, and T-lymphocyte persistence.

Purpose of the Study:

• To review the diagnostic challenges and current understanding of acute hepatitis C.
• To discuss the role of immune response in spontaneous viral clearance.
• To highlight the evolving treatment strategies and ongoing research needs.

Main Methods:

• Review of diagnostic criteria for acute hepatitis C, including antibody and viral RNA detection.
• Analysis of factors influencing HCV infection evolution, focusing on immune responses.
• Examination of current treatment recommendations and the rationale for delayed treatment initiation.

Main Results:

• Spontaneous viral clearance rates vary significantly (10-60%) and are associated with robust T-lymphocyte responses.
• Delaying treatment for 2-4 months post-onset does not negatively impact sustained virologic response rates.
• Post-clearance monitoring for viral rebound is necessary due to potential replication restart.

Conclusions:

• Despite advancements, diagnosing and managing acute hepatitis C requires further research into optimal treatment regimens and clearance mechanisms.
• Understanding the immune system's role is crucial for predicting and potentially enhancing viral clearance.
• Standardized guidelines for treatment timing, duration, and regimens are still needed for acute HCV.